» Articles » PMID: 25837691

Investigating Breast Cancer Cell Behavior Using Tissue Engineering Scaffolds

Overview
Journal PLoS One
Date 2015 Apr 4
PMID 25837691
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Despite early detection through the use of mammograms and aggressive intervention, breast cancer (BC) remains a clinical dilemma. BC can resurge after >10 years of remission. Studies indicate that BC cells (BCCs) with self-renewal and chemoresistance could be involved in dormancy. The majority of studies use in vitro, two-dimensional (2-D) monolayer cultures, which do not recapitulate the in vivo microenvironment. Thus, to determine the effect of three-dimensional (3-D) microenvironment on BCCs, this study fabricated tissue engineering scaffolds made of poly (ε-caprolactone) (PCL) having aligned or random fibers. Random and aligned fibers mimic, respectively, the random and highly organized collagen fibers found in the tumor extracellular matrix. Chemoresistant BCCs were obtained by treating with carboplatin. Western blot analysis of carboplatin resistant (treated) MDA-MB-231 (highly invasive, basal-like) and T47D (low-invasive, luminal) BCCs showed an increase in Bcl-2, Oct-4 and Sox-2, suggesting protection from apoptosis and increase in stem-like markers. Further studies with MDA-MB-231 BCCs seeded on the scaffolds showed little to no change in cell number over time for non-treated BCCs whereas on tissue culture polystyrene (TCP), non-treated BCCs displayed a significant increase in cell number at days 4 and 7 as compared to day 1 (p<0.05). Treated BCCs did not proliferate on TCP and the fibrous scaffolds. Little to no cyclin D1 was expressed for non-treated BCCs on TCP. On fibrous scaffolds, non-treated BCCs stained for cyclin D1 during the 7-day culture period. Treated BCCs expressed cyclin D1 on TCP and fibrous scaffolds during the 7-day culture period. Proliferation, viability and cell cycle analysis indicated that this 3-D culture prompted the aggressive BCCs to adopt a dormant phenotype, while the treated BCCs retained their phenotype. The findings indicate that random and aligned fibrous PCL scaffolds may provide a useful system to study how the 3-D microenvironment affects the behavior of BCCs.

Citing Articles

Nanostructured Biomaterials in 3D Tumor Tissue Engineering Scaffolds: Regenerative Medicine and Immunotherapies.

Angelopoulou A Int J Mol Sci. 2024; 25(10).

PMID: 38791452 PMC: 11121067. DOI: 10.3390/ijms25105414.


Current Advances in the Use of Tissue Engineering for Cancer Metastasis Therapeutics.

Katti P, Jasuja H Polymers (Basel). 2024; 16(5).

PMID: 38475301 PMC: 10934711. DOI: 10.3390/polym16050617.


Outlook and opportunities for engineered environments of breast cancer dormancy.

Richbourg N, Irakoze N, Kim H, Peyton S Sci Adv. 2024; 10(10):eadl0165.

PMID: 38457510 PMC: 10923521. DOI: 10.1126/sciadv.adl0165.


Programming temporal stiffness cues within extracellular matrix hydrogels for modelling cancer niches.

Major G, Ahn M, Cho W, Santos M, Wise J, Phillips E Mater Today Bio. 2024; 25:101004.

PMID: 38420142 PMC: 10900776. DOI: 10.1016/j.mtbio.2024.101004.


New Phenolic Glycosides from Lindl. var. and Their Cytotoxicity against Human Breast Cancer Cells.

Thant M, Bhummaphan N, Wuttiin J, Puttipanyalears C, Chaichompoo W, Rojsitthisak P ACS Omega. 2024; 9(7):7679-7691.

PMID: 38405545 PMC: 10883021. DOI: 10.1021/acsomega.3c07048.


References
1.
Fletcher D, Mullins R . Cell mechanics and the cytoskeleton. Nature. 2010; 463(7280):485-92. PMC: 2851742. DOI: 10.1038/nature08908. View

2.
Joyce J, Pollard J . Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009; 9(4):239-52. PMC: 3251309. DOI: 10.1038/nrc2618. View

3.
Cukierman E, Pankov R, Stevens D, Yamada K . Taking cell-matrix adhesions to the third dimension. Science. 2001; 294(5547):1708-12. DOI: 10.1126/science.1064829. View

4.
Benton G, George J, Kleinman H, Arnaoutova I . Advancing science and technology via 3D culture on basement membrane matrix. J Cell Physiol. 2009; 221(1):18-25. DOI: 10.1002/jcp.21832. View

5.
Lutolf M, Gilbert P, Blau H . Designing materials to direct stem-cell fate. Nature. 2009; 462(7272):433-41. PMC: 2908011. DOI: 10.1038/nature08602. View